cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Portage Biotech Inc
3 own
1 watching
Current Price
$5.58
$-0.1
(-1.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
65.04M
52-Week High
52-Week High
43.40000
52-Week Low
52-Week Low
2.10000
Average Volume
Average Volume
0.04M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization65.04M
icon52-Week High43.40000
icon52-Week Low2.10000
iconAverage Volume0.04M
iconDividend Yield--
iconP/E Ratio--
What does the Portage Biotech Inc do?
Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through the translational pipeline. The Company’s portfolio consists of four platforms, with lead programs consisting of invariant natural killer T-cell (iNKT) engagers and a suite of treatments targeting the adenosine pathway. Within these four platforms, the Company has nine product candidates, of which five are pre-clinical and four of which are clinical stage. The Company’s portfolio also includes small molecule adenosine inhibitors, such as PORT-6, PORT-7, PORT-8 and PORT-9, which represent targeting the adenosine pathway.
Read More
News & Events about Portage Biotech Inc.
Globe Newswire
1 year ago
WESTPORT, Conn., June 26, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, announced today that it has dosed the first patient in its Phase 1a trial, ADPORT-601...
Insider
1 year ago
The Food and Drug Administration approved Zavzpret, a nasal spray from Pfizer, on Friday. The medication is expected to hit shelves this July. Pfizer is releasing a new migraine drug.Carlo Allegri/Reuters The Food and Drug Administration on Friday approved a new nasal spray to treat migraines. The ...
Globe Newswire
1 year ago
WESTPORT, Conn., March 07, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, today announced that the Companys management team will be presenting virtually at ...
Globe Newswire
1 year ago
- Enrollment ongoing in IMPORT-201 Phase 1/2 trial of PORT-2 in Melanoma and Non-Small Cell Lung Cancer - Company on track to initiate Phase 1 portion of ADPORT-601 trial by end of 2Q23 - Company to Host a Key Opinion Leader Event on Targeting Adenosine Pathway in Cancer WESTPORT, Conn., March 01, ...
Globe Newswire
1 year ago
WESTPORT, Conn., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as single agents and in combination, today announced that the Companys management team will participate in a fireside chat...
Frequently Asked Questions
Frequently Asked Questions
What is Portage Biotech Inc share price today?
plus_minus_icon
Can Indians buy Portage Biotech Inc shares?
plus_minus_icon
How can I buy Portage Biotech Inc shares from India?
plus_minus_icon
Can Fractional shares of Portage Biotech Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Portage Biotech Inc stocks?
plus_minus_icon
What is today’s traded volume of Portage Biotech Inc?
plus_minus_icon
What is today’s market capitalisation of Portage Biotech Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Portage Biotech Inc?
plus_minus_icon
What percentage is Portage Biotech Inc down from its 52-Week High?
plus_minus_icon
What percentage is Portage Biotech Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.58
$-0.1
(-1.76%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00